Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC
JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter

More articles from psychopharmacology for the clinician

  • Open Access
    Serotonin syndrome: SSRIs are not the only culprit
    Nicolas Garel, Kyle T. Greenway, Karim Tabbane and Ridha Joober
    J Psychiatry Neurosci May 01, 2021 46 (3) E369-E370; DOI: https://doi.org/10.1503/jpn.210001
  • Open Access
    Binge eating disorder hidden behind a wall of anxiety disorders
    Amy Pipe, Beth Patterson and Michael Van Ameringen
    J Psychiatry Neurosci March 01, 2021 46 (2) E208-E209; DOI: https://doi.org/10.1503/jpn200235
  • Open Access
    Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination
    Deborah Thompson, Clay M. Delorme, Randall F. White and William G. Honer
    J Psychiatry Neurosci March 01, 2021 46 (2) E210-E211; DOI: https://doi.org/10.1503/jpn.210027
  • Open Access
    The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
    Nicolas Garel, Kyle T. Greenway and Ridha Joober
    J Psychiatry Neurosci January 01, 2021 46 (1) E164-E165; DOI: https://doi.org/10.1503/jpn.200114
  • You have access
    Therapeutic abstention in the treatment of depression in first-episode psychosis
    Priyadharshini Sabesan and Lena Palaniyappan
    J Psychiatry Neurosci November 01, 2020 45 (6) 441-442; DOI: https://doi.org/10.1503/jpn.200059
  • You have access
    Treating anxious syndromes with pregabalin in patients with psychosis
    Nicolas Garel, David Bloom and Ridha Joober
    J Psychiatry Neurosci September 01, 2020 45 (5) 370; DOI: https://doi.org/10.1503/jpn.200033
  • You have access
    Long-acting injectable antipsychotics: choosing the right dose
    David Carlone and Nicholas Delva
    J Psychiatry Neurosci July 01, 2020 45 (4) 298; DOI: https://doi.org/10.1503/jpn.200015
  • You have access
    Consensus statement on the use of clozapine during the COVID-19 pandemic
    Dan Siskind, William G. Honer, Scott Clark, Christoph U. Correll, Alkomiet Hasan, Oliver Howes, John M. Kane, Deanna L. Kelly, Robert Laitman, Jimmy Lee, James H. MacCabe, Nick Myles, Jimmi Nielsen, Peter F. Schulte, David Taylor, Helene Verdoux, Amanda Wheeler and Oliver Freudenreich
    J Psychiatry Neurosci May 01, 2020 45 (3) 222-223; DOI: https://doi.org/10.1503/jpn.200061
  • You have access
    Mu-opioid antagonism in the treatment of cannabis use disorder
    Oussama Kebir, Xavier Laqueille and Fayçal Mouaffak
    J Psychiatry Neurosci March 01, 2020 45 (2) 143-144; DOI: https://doi.org/10.1503/jpn.190182
  • You have access
    Kleptomania treated with naltrexone in a patient with intellectual disability
    Faycal Mouaffak, Sonia Hamzaoui, Oussama Kebir and Xavier Laqueille
    J Psychiatry Neurosci January 01, 2020 45 (1) 71-72; DOI: https://doi.org/10.1503/jpn.190064

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 13

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1180-4882.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].
View CMA's Accessibility policy.

Powered by HighWire